000 | 01595 a2200409 4500 | ||
---|---|---|---|
005 | 20250514012310.0 | ||
264 | 0 | _c20011205 | |
008 | 200112s 0 0 eng d | ||
022 | _a0006-2960 | ||
024 | 7 |
_a10.1021/bi011040y _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLewinson, O | |
245 | 0 | 0 |
_aEvidence for simultaneous binding of dissimilar substrates by the Escherichia coli multidrug transporter MdfA. _h[electronic resource] |
260 |
_bBiochemistry _cOct 2001 |
||
300 |
_a12612-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBacterial Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aBenzalkonium Compounds _xpharmacology |
650 | 0 | 4 |
_aBenzimidazoles _xpharmacology |
650 | 0 | 4 |
_aBiological Transport _xdrug effects |
650 | 0 | 4 |
_aChloramphenicol _xmetabolism |
650 | 0 | 4 |
_aDaunorubicin _xpharmacology |
650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xgenetics |
650 | 0 | 4 |
_aEscherichia coli _xgenetics |
650 | 0 | 4 | _aEscherichia coli Proteins |
650 | 0 | 4 |
_aEthidium _xpharmacology |
650 | 0 | 4 | _aMembrane Transport Proteins |
650 | 0 | 4 |
_aOnium Compounds _xantagonists & inhibitors |
650 | 0 | 4 |
_aOrganophosphorus Compounds _xantagonists & inhibitors |
650 | 0 | 4 |
_aProtein Binding _xdrug effects |
650 | 0 | 4 |
_aRecombinant Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 |
_aTritium _xmetabolism |
700 | 1 | _aBibi, E | |
773 | 0 |
_tBiochemistry _gvol. 40 _gno. 42 _gp. 12612-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/bi011040y _zAvailable from publisher's website |
999 |
_c11521657 _d11521657 |